The business fate of several e-pharmacies in India appears to hang in the balance after a round of unfavorable court orders that have disallowed online sales of medicines in the country. At stake is also millions of dollars pumped into the promising segment, though industry experts believe that savvy investors will likely ride out the storm.
Though appeals against the orders are expected, what makes the situation piquant is that the Indian government had recently notified draft rules pertaining to the sale of drugs by e-pharmacies, including mandatory registration of e-pharmacies and norms to monitor their online sales
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?